5 terminated. 5 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Terminated 5 |
| Phase 2 | 5 | Terminated 5 |
Follow Fibrosarcoma: new trials by email Literature Review of Fibrosarcoma trials Research Report on Fibrosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors TNG908 - Locally Advanced Solid Tumor | Phase 1 / Phase 2 | Terminated | Tango Therapeutics, Inc. | 110 | 2022-03-23 | 2026-04-15 |
| A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis AL2846 capsules - Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors | Phase 1 / Phase 2 | Terminated | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 22 | 2021-09-07 | 2024-03-21 |
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Pazopanib, Pazopanib Hydrochloride, Sapanisertib - High Grade Sarcoma, Metastatic Leiomyosarcoma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 151 | 2015-11-30 | 2022-08-23 |
| PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors PLX3397, sirolimus - Sarcoma, Malignant Peripheral Nerve Sheath Tumors | Phase 1 / Phase 2 | Terminated | Gulam Manji | 39 | 2015-11-04 | 2025-03-21 |
| Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) Pazopanib 400 mg QD - Gemcitabine and Docetaxel in Combination - Sarcoma, Leiomyosarcoma | Phase 1 / Phase 2 | Terminated | Memorial Sloan Kettering Cancer Center | 5 | 2011-08-01 | 2018-01-11 |
Neurofibrosarcoma (5) · Sarcoma (3) · Histiocytoma, Malignant Fibrous (2) · Leiomyosarcoma (2) · Cholangiocarcinoma (1) · Dermatofibrosarcoma (1) · Glioblastoma (1) · Histiocytoma (1) · Mesothelioma (1) · Neurofibromatoses (1) · Sarcoma, Synovial (1)
Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Connective Tissue (5) · Neoplasms, Connective and Soft Tissue (5) · Neoplasms, Fibrous Tissue (5) · Neoplasms, Nerve Tissue (5) · Nerve Sheath Neoplasms (5) · Nervous System Diseases (5) · Nervous System Neoplasms (5) · Neurofibroma (5) · Neuromuscular Diseases (5) · Peripheral Nervous System Diseases (5) · Peripheral Nervous System Neoplasms (5) · Neoplasms, Muscle Tissue (2)
pazopanib (2) · Docetaxel (1) · Sirolimus (1) · pexidartinib (1) · sapanisertib (1)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Gulam Manji (1) · Memorial Sloan Kettering Cancer Center (1) · National Cancer Institute (NCI) (1) · Tango Therapeutics, Inc. (1)
United States (4) · China (1) · France (1)
Gulam A. Manji, MD (1) · Maxim Pimkin, MD, PhD (1) · William D Tap (1) · William Tap, MD (1)
U10CA180821 (1)